Keyphrases
Hepatocellular Carcinoma Cells
100%
Metabolic Reprogramming
100%
Eukaryotic Translation Initiation Factor 5A2
100%
Hepatocellular Carcinoma
27%
MRNA Level
18%
Fatty Acids
18%
Overexpression
18%
Messenger RNA (mRNA)
18%
Liver Cancer Treatment
18%
Glycolysis
9%
Hypoxic Condition
9%
Hepatocellular Carcinoma Progression
9%
Glucose Transporter 1 (GLUT1)
9%
Oncogene
9%
Phosphofructokinase
9%
RNA-protein Complex
9%
Lipogenesis
9%
Acetate
9%
Hexokinase
9%
Aerobic Glycolysis
9%
Glucose Uptake
9%
Tumorigenesis
9%
Novel Therapeutic Targets
9%
Clinical Samples
9%
Lactate Dehydrogenase
9%
Cell Growth
9%
Glucose Transporter 2 (GLUT2)
9%
Ectopic Expression
9%
Survival Time
9%
Biosynthetic Pathway
9%
Liver Cancer Stem Cells
9%
Abnormal Activity
9%
Liver Type
9%
Lactate Secretion
9%
ACSS2
9%
Glyceraldehyde-3-phosphate Dehydrogenase
9%
M2 Isoform of Pyruvate Kinase
9%
Intracellular Metabolism
9%
Phosphoglycerate mutase
9%
Glucose Utilization
9%
Biochemistry, Genetics and Molecular Biology
Reprogramming
100%
Eukaryotic Translation
100%
Initiation Factor
100%
Messenger RNA
18%
Enzyme
18%
Anabolism
18%
Metabolic Pathway
9%
Isoform
9%
Cancer Cell
9%
Glucose Transporter
9%
Pyruvate Kinase
9%
Phosphofructokinase
9%
Aerobic Glycolysis
9%
Hexokinase
9%
Glucose Transport
9%
Carcinogenesis
9%
Secretion (Process)
9%
Cell Growth
9%
Lactate Dehydrogenase
9%
Ectopic Expression
9%
Survival Time
9%
Oncogene
9%
Lipogenesis
9%
Glyceraldehyde 3-Phosphate Dehydrogenase
9%
Phosphoglycerate Mutase
9%
Glucose Utilization
9%